The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients
<p>Abstract</p> <p>Background</p> <p>Allergic rhinitis (AR) is a common problem and we sought to examine the burden of disease and its management in Canada from the perspectives of patients and physicians.</p> <p>Methods</p> <p>Two parallel, Cana...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-06-01
|
| Series: | Allergy, Asthma & Clinical Immunology |
| Subjects: | |
| Online Access: | http://www.aacijournal.com/content/8/1/7 |
| _version_ | 1818677407162302464 |
|---|---|
| author | Keith Paul K Desrosiers Martin Laister Tina Schellenberg R Waserman Susan |
| author_facet | Keith Paul K Desrosiers Martin Laister Tina Schellenberg R Waserman Susan |
| author_sort | Keith Paul K |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Allergic rhinitis (AR) is a common problem and we sought to examine the burden of disease and its management in Canada from the perspectives of patients and physicians.</p> <p>Methods</p> <p>Two parallel, Canadawide structured telephone interviews surveyed 1,001 AR patients and 160 physicians in July 2006.</p> <p>Results</p> <p>44% of patients had experienced nasal symptoms unrelated to a cold and 20% had a physician diagnosis of AR. At screening 27% reported asthma, 15% chronic or recurrent sinusitis and 5% nasal polyps. With attacks nasal congestion and runny nose were the most bothersome symptoms. Other problems experienced were fatigue (46%), poor concentration (32%), and reduced productivity (23%). Most (77%) had not seen a physician in the past year. Physicians estimated they prescribed intranasal cortico steroids (INCS) to most AR patients (77%) consistent with guidelines but only 19% of patients had used one in the last month. Only 48% of patients were very satisfied with their current INCS. 41% of AR patients reported discontinuing their INCS with the most common reason being a perceived lack of long-lasting symptom relief (44%). 52% of patients felt that their current INCS lost effectiveness over 24 h. The most common INCS side effects included dripping down the throat, bad taste, and dryness. Most AR patients reported lifestyle limitations despite treatment (66%). 61% of patients felt that their symptoms were only somewhat controlled or poorly/not controlled during their worst month in the past year.</p> <p>Conclusions</p> <p>AR symptoms are common and many patients experience inadequate control. Physicians report they commonly prescribe intranasal corticosteroids, but patient’s perceived loss of efficacy and side effects lead to their discontinuation. Persistent relief of allergic rhinitis symptoms remains a major unmet need. Better treatments and education are required.</p> |
| first_indexed | 2024-12-17T08:58:53Z |
| format | Article |
| id | doaj.art-30913f28212c4a4b9e3b681c156275d4 |
| institution | Directory Open Access Journal |
| issn | 1710-1484 1710-1492 |
| language | English |
| last_indexed | 2024-12-17T08:58:53Z |
| publishDate | 2012-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Allergy, Asthma & Clinical Immunology |
| spelling | doaj.art-30913f28212c4a4b9e3b681c156275d42022-12-21T21:55:50ZengBMCAllergy, Asthma & Clinical Immunology1710-14841710-14922012-06-0181710.1186/1710-1492-8-7The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patientsKeith Paul KDesrosiers MartinLaister TinaSchellenberg RWaserman Susan<p>Abstract</p> <p>Background</p> <p>Allergic rhinitis (AR) is a common problem and we sought to examine the burden of disease and its management in Canada from the perspectives of patients and physicians.</p> <p>Methods</p> <p>Two parallel, Canadawide structured telephone interviews surveyed 1,001 AR patients and 160 physicians in July 2006.</p> <p>Results</p> <p>44% of patients had experienced nasal symptoms unrelated to a cold and 20% had a physician diagnosis of AR. At screening 27% reported asthma, 15% chronic or recurrent sinusitis and 5% nasal polyps. With attacks nasal congestion and runny nose were the most bothersome symptoms. Other problems experienced were fatigue (46%), poor concentration (32%), and reduced productivity (23%). Most (77%) had not seen a physician in the past year. Physicians estimated they prescribed intranasal cortico steroids (INCS) to most AR patients (77%) consistent with guidelines but only 19% of patients had used one in the last month. Only 48% of patients were very satisfied with their current INCS. 41% of AR patients reported discontinuing their INCS with the most common reason being a perceived lack of long-lasting symptom relief (44%). 52% of patients felt that their current INCS lost effectiveness over 24 h. The most common INCS side effects included dripping down the throat, bad taste, and dryness. Most AR patients reported lifestyle limitations despite treatment (66%). 61% of patients felt that their symptoms were only somewhat controlled or poorly/not controlled during their worst month in the past year.</p> <p>Conclusions</p> <p>AR symptoms are common and many patients experience inadequate control. Physicians report they commonly prescribe intranasal corticosteroids, but patient’s perceived loss of efficacy and side effects lead to their discontinuation. Persistent relief of allergic rhinitis symptoms remains a major unmet need. Better treatments and education are required.</p>http://www.aacijournal.com/content/8/1/7Rhinitis, AllergicAnti-allergic agentsAdministration, IntranasalQuality of life |
| spellingShingle | Keith Paul K Desrosiers Martin Laister Tina Schellenberg R Waserman Susan The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients Allergy, Asthma & Clinical Immunology Rhinitis, Allergic Anti-allergic agents Administration, Intranasal Quality of life |
| title | The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients |
| title_full | The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients |
| title_fullStr | The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients |
| title_full_unstemmed | The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients |
| title_short | The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients |
| title_sort | burden of allergic rhinitis ar in canada perspectives of physicians and patients |
| topic | Rhinitis, Allergic Anti-allergic agents Administration, Intranasal Quality of life |
| url | http://www.aacijournal.com/content/8/1/7 |
| work_keys_str_mv | AT keithpaulk theburdenofallergicrhinitisarincanadaperspectivesofphysiciansandpatients AT desrosiersmartin theburdenofallergicrhinitisarincanadaperspectivesofphysiciansandpatients AT laistertina theburdenofallergicrhinitisarincanadaperspectivesofphysiciansandpatients AT schellenbergr theburdenofallergicrhinitisarincanadaperspectivesofphysiciansandpatients AT wasermansusan theburdenofallergicrhinitisarincanadaperspectivesofphysiciansandpatients AT keithpaulk burdenofallergicrhinitisarincanadaperspectivesofphysiciansandpatients AT desrosiersmartin burdenofallergicrhinitisarincanadaperspectivesofphysiciansandpatients AT laistertina burdenofallergicrhinitisarincanadaperspectivesofphysiciansandpatients AT schellenbergr burdenofallergicrhinitisarincanadaperspectivesofphysiciansandpatients AT wasermansusan burdenofallergicrhinitisarincanadaperspectivesofphysiciansandpatients |